“Psychedelics are the next big thing,” Ronan Levy, co-founder of Field Trip Psychedelics, an integrated company in legal psychedelics and psychedelic-assisted psychotherapy, told me during a lunch in New York City a few months ago. He looked perfectly sane, wearing a suit, and articulating properly.
He was definitely not tripping.
But what the hell did he mean by psychedelics are the next big thing? Did he really think America would be taking mushrooms like they do beer?
I was very skeptical.
But it’s not about recreational use, really, he explained. Although psychedelics can be used for recreation, and there’s nothing wrong with that, for Levy it’s all about the therapeutic potential of these substances, which can be used in the treatment of depression, PTSD, and other conditions.
“The evidence supporting the therapeutic use of psychedelics is becoming too compelling to ignore,” he told me.
Field Trip also plans to open clinics globally, taking a “broad spectrum approach” to backing psychedelic research, starting with applications in mental health and building cultivation centers for medical-grade magic mushrooms, he explained.